Last reviewed · How we verify
Tandetoron (alprostadil alfadex)
Tandetoron (generic name: alprostadil alfadex) is a Prostaglandin Analog drug. It is currently in unknown development.
Tandetoron works by binding to and activating prostaglandin receptors in the body, mimicking the natural prostaglandin prostaglandin E1.
Tandetoron (alprostadil alfadex) is a prostaglandin analog, a small molecule drug that works by mimicking the effects of a natural prostaglandin in the body. It is used to treat certain conditions, although its specific indications are not provided. The commercial status of Tandetoron is unknown, and it may be patented or have generic manufacturers. Key safety considerations are not specified. Further information is needed to provide a comprehensive summary.
At a glance
| Generic name | alprostadil alfadex |
|---|---|
| Drug class | Prostaglandin Analog |
| Therapeutic area | Hematology |
| Phase | unknown |
Mechanism of action
Think of prostaglandins like messengers that help blood vessels relax and improve blood flow. Tandetoron sends a similar message to the body, helping to widen blood vessels and improve blood flow to specific areas. This can be helpful for conditions where blood flow is a problem.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tandetoron CI brief — competitive landscape report
- Tandetoron updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Tandetoron
What is Tandetoron?
How does Tandetoron work?
What is the generic name of Tandetoron?
What drug class is Tandetoron in?
What development phase is Tandetoron in?
Related
- Drug class: All Prostaglandin Analog drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Hematology
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing